Download AlCC progrAm - Australian Lung Cancer Conference

ALCC PROGRAM
Wednesday 15 October
8.00am - 6.00pm
Registration Desk Opens
Plaza Terrace Foyer
9.00am - 5.00pm
Australia and New Zealand Lung Cancer Nurses Forum - Lung
Cancer Workshop
Plaza P6 - P7
W-1 Lung Cancer - Let’s set the scene
9.00am - 10.30am
10.30am - 11.00am
Chair: Craig Scharf
9.00am Welcome
9.05am A snapshot of review: Lungs and Lung Cancer
9.20am Lung cancer screening: Where is Australia at?
9.35am Transitioning nursing research in practice
9.50am ATSI patients - Cultural understanding in clinical practice
10.05am Interpreting radiology results
Craig Scharf
Kwun Fong
Henry Marshall
Mei Krishnasamy
Janiece Coates
Peter Jackson
Plaza P6 - P7
Morning tea
W-2 Latest advances and emerging therapies
11.00am -12.30pm
12.30pm - 1.30pm
Chair: Louise Underhill
11.00am Emerging systemic therapies
11.30am Recent advances in radiotherapy for lung cancer
12.00am Treatment decisions for lung cancer patients
Pretoria Bilinski
David Ball
Craig Underhill
Plaza P6 - P7
Lunch
W-3 Supporting patients, their carers and families: Practical tips
for clinical practice
1.30pm - 3.00pm
Chair: Jan Whelan
1.30pm Managing the symptoms of lung cancer
2.00pm What is survivorship in lung cancer?
2.30pm Palliative care: Planning end of life care
3.00pm - 3.30pm
Afternoon Tea
Patsy Yates
Natalie Doyle
Mark Deuble
Plaza P6 - P7
W-4 Getting it right - Where are we now?
Closing session
3.30pm - 5.00pm
Chair: Mary Duffy
3.30pm Smoking cessation: An integral part of lung cancer treatment
3.55pm The great hypothetical: Right care - Right time - Right place
4.55pm Close
10.00am - 12.00pm Lung Cancer Network Australia - Consumer/Patient seminar
Plaza P6 - P7
Caroline Rae
Facilitator - Jane Turner
Mary Duffy
Arbor 1
1.00pm - 2.30pm
ALTG MAC Meeting (closed meeting)
Boulevard B3
2.45pm - 5.00pm
ALTG Open Scientific Advisory Committee (SAC) Meeting
Boulevard B3
5.00pm - 6.30pm
ALTG General Meeting
Boulevarde B3
5.00pm - 5.30pm
ANZ-LCNF members meeting (Closed meeting)
Plaza P6 & P7
7.00pm - 9.00pm
Lung Cancer National Program Advisory Committee Meeting
(Closed meeting)
Arbor 1
Australian Lung C ancer Conference
Brisbane CONVENTION CENTRE • 16 -18 OCTOBER 2014
19
Thursday 16 OCTOBER
6.00am - 7.30pm
Registration desk opens
Plaza Terrace Foyer
7.30am - 8.30am
Lilly sponsored breakfast symposium
Plaza P9 - P11
T-1 Opening ceremony and plenary session 1:
proudly sponsored by Verastem inc.
Getting it right - Where are we now?
8.45am - 10.00am
Chairs: Kwun Fong and Craig Scharf
8.45am Welcome and official opening
9.10am Lung cancer in Australia
9.25am How do we learn from data?
9.45am Where are the opportunities?
10.00am - 10.30am
Heather Allan and
David Serisier
Helen Zorbas
Martin Stockler
Michael Boyer
Morning tea (exhibition and poster viewing)
Plaza Auditorium
Plaza Terrace Room
T-2 Radiotherapy
Chairs: David Ball and Mike Fay
10.30am Radiotherapy, biology and new platforms
11.00am Optimising radiotherapy fractionation in locally advanced
non-small cell lung cancer: design of next generation trials
11.30am Radiotherapy and chemotherapy
Billy Loo
Plaza Auditorium
Noelle O’Rourke
Michael Millward
T-3 Abstract orals
Chairs: Shawgi Sukamaran and Andrew Davidson
10.30am 19037_2 Equity of access to non-small cell lung cancer
surgery in Queensland: a population-based study
10.45am 19019_1 Safety and clinical activity of pembrolizumab (MK3475) as initial therapy for advanced NSCLC
10.55am 19019_2 Safety and clinical activity of pembrolizumab (MK3475) in patients with previously treated NSCLC
11.05am Discussant
11.20am 19024 Prospective multiplex molecular testing in 1280
10.30am - 12.00pm NSCLC patients:The Victorian lung cancer initiative
11.35am 17951 Accuracy of oncologists’ survival estimates for
advanced lung cancer patients starting chemotherapy
11.50am Discussant
T-4 Cancer control - proudly sponsored
by Cancer Institute NSW
Chairs: Shoni Colquist and Tracey Guan
10.30am lung cancer around the country - roundtable
11:10am Lessons from the UK
11.30am Abstract Oral 18968_1 Quality in lung cancer care: The
Victorian Lung Cancer Registry pilot initial report
11.40am Abstract oral 18968_3 Gap analysis if Victorian Lung Cancer
Registry Data after 3 years: Evaluation of MDT variables
11.50am Abstract oral 18356 Mesothelioma in Australia 2013:
Recent data from the Australian Mesothelioma Registry
Nathan Dunn
Rina Hui
Rina Hui
Plaza P6 - P7
Keith Horwood
Ben Solomon
Belinda Kiely
Prunella Blinman
David Currow, Paul
Mitchell, Annette
McWilliams, Cameron
Hunter, Jeff Bowden
John Field
Rob Stirling
Plaza P8
Wendy Bower
Fraser Brims
12.00pm - 1.30pm
Networking lunch (exhibition and poster viewing)
Plaza Terrace Room
12.15pm - 1.15pm
Roche sponsored lunch symposium: NSCLC Treatment in the Era
of Targeted Therapies: Current and Future Considerations
Plaza P9 - P11
Optimal lung cancer care right care – right time – right place
Thursday 16 OCTOBER
T-5 Chewing through lung cancer - bite-sized updates
Chairs - Martin Stockler and Tim Christmas
1.30pm Staging news - What’s next?
2.00pm Advances in pleural management
2.15pm Impact of COPD on lung cancer diagnosis and treatment
2.30pm SCLC biology
2:45pm SCLC treatment advances
3.00pm MDT lung cancer care - Room for improvement?
3.15pm Follow-up and survivorship
David Ball
Farzad Bashirzadeh
Ian Yang
Paul Mainwaring
Noelle O’Rourke
David Barnes
Haryana Dhillon
Plaza Auditorium
T-6 Young investigator/Fellow abstract orals
1.30pm - 3.30pm
Chairs: Paul Mitchell and Rayleen Bowman
1.30pm 19012_1 RON/MST1R is a potential new therapeutic target
in malignant pleural mesothelioma 1.45pm 18380 NY-ESO-1 promoter methylation is repressible using
5-aza and influences chemosensitivity in NSCLC
2.00pm 19034 Mediastinal staging in NSCLC – a comparison
of outcomes following sampling via surgery and EBUS-TBNA
2.15pm Discussant
2.30pm 18978 Genomics of NSCLC, Victoria; molecular profiling
identifies high incidence of actionable alterations
2.45pm 18355 An audit of quality of care parameters at end
of life in advanced lung cancer 3.00pm 18893_3 CT screening: A community prospective cohort
study incorporating a gene-based lung cancer risk test
3.15pm Discussant
Anne-Marie Baird
Sem Liew
John Taverner
Chris Karapetis
Tali Lior
Plaza P6 - P7
Jaclyn Yoong
Raewyn Hopkins
Rayleen Bowman
T-7 Supportive Assistance - Strategic/Overarching Topics
Chairs: Robyn Berry and Beth Ivimey
1.30pm A snapshot of 40 years of supportive care
innovation in lung cancer
2.00pm Comprehensive Geriatric Assessment
of Older Lung Cancer Patient
2.20pm QCCAT Score card in lung cancer
2.40pm Let’s yarn about lung cancer – an indigenous rural project
3.00pm Health and well-being
3.30pm to 4.00pm
Mei Krishnasamy
Sandie McCarthy
Plaza P8
Craig Scharf
Robyn Sharman
Natalie Doyle
Afternoon tea (exhibition and poster viewing)
Plaza Terrace Room
T-8 Controversies - A friendly debate
Chairs: Peter Flynn and Michael Michael
4.00pm Mini Debate: Is there a role for surgery in 3A disease:
Surgery for 3A NSCLC case pre-operative neo-adjvuvent therapy vs
post-operative adjuvant therapy
4.25pm Mini Debate: SBRT vs ablation vs surgery
5.10pm E-cigarettes are a bad/good idea?
Gavin Wright vs Morgan
Windsor
Billy Loo vs Karin Steinke vs
Stephen Barnett
Cameron Hunter vs
Matthew Peters
Plaza Auditorium
T-9 Abstract orals
4.00pm - 5.30pm
Chairs: Phillip Antippa and Nick Pavlakis
4.00pm 19031_1 PD-L1 expression is a favourable prognostic factor in
early stage NSCLC
4.15pm 18939_1 Use of 4D ventilation/perfusion (V/Q) PET/CT
for adaptive intensity modulated radiotherapy (IMRT)
4.30pm 19041 Patient-derived xenograft models of lung squamous
cell carcinoma to evaluate novel targeted therapy
4.45pm Discussant
4.53pm 18062 Building an implementation science program in
lung cancer care: the Sydney Catalyst experience
5.08pm 19124 Healthcare professional perceptions regarding
chemotherapy use in treatment of Malignant Pleural Mesothelioma
(MPM): quantitative survey results
5.22pm Discussant
Wendy Cooper
Shankar Siva
Marie-Liesse Asselin-Labat
Michael MacManus
Nicole Rankin
Haryana Dhillon
Cathy Crombie
Plaza P6 - P7
Australian Lung C ancer Conference
Brisbane CONVENTION CENTRE • 16 -18 OCTOBER 2014
21
Thursday 16 OCTOBER
T-10 Emotional and Psychosocial Challenges in Lung Cancer
4.00pm - 5.30pm
5.30pm - 7.00pm
Chairs: Mary Duffy and Kahren White
4.00pm Stigma and Nihilism in Lung Cancer
4.20pm Eliciting and responding to emotonal cues
4.55pm Mindfulness training as offered by CCQld
5.15pm Panel discussion
Suzanne Chambers
Jodie Nixon & Lyndal Gray
Sylvia Burns
All
Plaza P8
ALCC Welcome Reception
Plaza Terrace Room
Indigenous lung cancer health professionals (Closed meeting)
Plaza P9 - P11
Lung screening interest group meeting (Open meeting)
6.45pm Arrival/Registration
7.00pm Welcome
7.05pm Updates from efforts/research from around Australia
7.00pm - 9.00pm
7.20pm Update of international guidelines and recommendations
including US Preventative Task Force
7.30pm Can we?
7.40pm Should we?
7.50pm How do we?
8.00pm Can we afford to?
8.10pm Role of ALTG
8.20pm Moving forward - thematic strategies - Round table discussion
9.00pm Summary & Close
Annette McWilliams and
Lou Irving
Audience invited to
participate
Henry Marshall
Plaza P8
Annette McWilliams
Matthew Peters
David Langton
Karen Canfell
Paul Mitchell
Facilitators - Eddie Lau and
Fraser Brims
Lou Irving and Annette
McWilliams
Eli Lilly Australia Pty Limited, ACN 000 233 992, 112 Wharf Road West Ryde,
NSW 2114, Ph +61 2 9325 4444. Sept 2014 AUONC00159
Optimal lung cancer care right care – right time – right place
FRIDAY 17 OCTOBER
6.30am - 6.00pm
Registration Desk Opens
Plaza Terrace Foyer
7.30am - 8.30am
Bristol Myers Squibb breakfast symposium: Evolving Treatment
paradigms in lung cancer – Role of Immuno-Oncology
Plaza P9 - P11
F-1 Plenary session 2: Screening and early detection
9.00am - 10.30am
10.30am - 11.00am
Chairs: David Langton and Nico van Zandwijk
9.00am Screening in Australia – Relevance to lung cancer
9.20am Image based lung cancer screening
10.00am Early detection with biomarkers
Renee Manser
John Field
David Carbone
Morning tea (poster display & exhibition)
Plaza Auditorium
Plaza Terrace Room
F-2 Biomarker testing
Chairs - Michael MacManus and Edwina Duhig
11.00am State of the art molecular pathology
11.30am Right molecule - genomic biomarkers in tumours?
12.00pm Right test, right interpretation?
Keith Kerr
Prue Russell
Wendy Cooper
Plaza Auditorium
F-3 Abstract orals
Chairs: Michelle Murphy and David Leong
11.00am 18968_5 Health service variables impact timelines
of care in Victorian lung cancer
11.15am 18136_2 Dacomitinib vs placebo in heavily pretreated
advanced NSCLC: BR26 A NCIC CTG, ALTG, NCI Naples trial
11.30am 19012_2 Targeting NF-KB pathways as a means to
overcome cisplatin resistance in non-small cell lung cancer
11.45am Discussant
11.55am 18893_2 Favourable stage-shift in participants with
11.00am - 12.30pm baseline COPD in a biomarker sub-study of the NLST
12.05pm 18893_1 SNP data with clinical risk: a model for
lung cancer to improve lung cancer detection in the NLST
12.15pm 18936 Preferences for adjuvant chemotherapy in
non-small-cell lung cancer: what makes it worthwhile
12.25pm Discussant
Rob Stirling
Michael Millward
Anne-Marie Baird
Martin Phillips
Rob Young
Plaza P6 - P7
Rob Young
Prunella Blinman
Ben Solomon
F-4 Physical considerations in lung cancer
Chairs: Louise Underhill and Haryana Dhillon
11:00 Complementary and Alternative Medicine: A Dietitian’s
perspective and implications for the MDT
11:15 Managing physical deterioration in lung cancer
11:30 Fatigue management in lung cancer
12:00 Abstract oral - 18986 Nutritional risks following extrapleural
pneumonectomy for malignant pleural mesothelioma
12:15 Lung cancer, a chronic disease - Examining the concept
of self-management
Jamie Fieldman
Catherine Granger
Ray Chan
Jason Fowler
Plaza P8
Tamirin Darch and
Jacob Darch
12.30pm - 2.00pm
Networking lunch (exhibition and poster viewing)
Plaza Terrace Room
12.45pm - 1.45pm
Boehringer Ingelheim sponsored lunch symposium
Title: Targeted therapies in NSCLC: Insights and understanding
Plaza P9 - P11
Australian Lung C ancer Conference
Brisbane CONVENTION CENTRE • 16 -18 OCTOBER 2014
23
FRIDAY 17 OCTOBER
F-5 Diagnosis and staging: Today’s diagnosis
Chairs: Prue Russell and David Fielding
2.00pm Advances in bronchology
2.15pm Anatomical pathology – Update
2.45pm Genetic testing - simplex/multiplex in real life
3.00pm The right lung cancer workflow in the city and the bush
3.15pm PET and MRI - Ready for prime time - Brief update
Daniel Steinfort
Keith Kerr
James Harraway
Edwina Duhig
Mike Fay
Plaza Auditorium
F-6 Grand Rounds : What to do and when –
How to handle these cases
2.00pm - 3.30pm
Chairs: Ken O’Byrne and Michael Millward
2.00pm Introduction
2.15pm Stage 3A
2.30pm Stage 3B
2.45pm Stage 4 Oligometastatic disease
Plaza P6 - P7
F-7 Hot topics in current practice
Chairs: Jocelyn McLean and Robert Tam
2.00pm Tobacco cessation - medication update
2.20pm Tobacco cessation and screening
2.40pm Nicotine and its effects on lung cancer and COPD
2:55pm Do Aboriginal and Torres Strait Islander people with
lung cancer receive optimal cancer treatment?
3.10pm Modelling cancer screening with relevance to lung cancer
3.30pm - 4.00pm
Peter Robinson
John Field
Rob Young
Patricia Valery
Plaza P8
Karen Canfell
Afternoon tea (poster display & exhibition)
Plaza Terrace Room
F-8 Science, neuroendocrine tumours and mesothelioma
Chairs: Nick Pavlakis and Fraser Brims
4.00pm Stem cell tumours - biology
4.15pm Science of risk factors beyond smoking
4.30pm Mesothelioma - Close to the peak?
4.45pm Wittenoom cohort - Where are they now?
5.00pm Mesothelioma treatment advances
5.15pm Discussion
Tom John
Rob Young
Nico van Zandwijk
Bill Musk
Keith Horwood
All
Plaza Auditorium
F-9 Emerging challenges
4.00pm - 5.30pm
Chairs: Annette McWilliams and Stephen Barnett
4.00pm Nodule radiological definitions e.g. LungRAD
4.15pm Rebiopsy or not? After disease progression on TKIs
4.30pm Pathological challenges with post-treatment biopsies
4.45pm Emerging technologies for the surgical management
of lung cancer
5.15pm Rebiopsy and how? If not mutation testable
Karin Steinke
Brett Hughes
Keith Kerr
Kazuhiro Yasufuku
Plaza P6 - P7
Louis Irving
F-10 Abstract orals
Chairs: Shawgi Sukamaran and Chris Karapetis
4.00pm 18968_2 A comparison of the use of ICD-10 coding
data and manual data extraction in comorbidity assessment 4.15pm 19037_1 Predictors of postoperative mortality
after lung cancer surgery 4.30pm Discussant
4.45pm 17514_2 An audit and evaluation of the lung cancer
pathway: metropolitan and non-metropolitan.
5.00pm 18964_2 Comparison of public NSCLC patients
reviewed by MDT in Central and Southern Qld
5.15pm Discussant
7.00pm - 10.30pm
Wendy Bower
Nathan Dunn
Robert Tam
Barbara Page
Plaza P8
Tracey Guan
Kathleen Houston
ALCC Gala Dinner
Optimal lung cancer care right care – right time – right place
Rydges Southbank
SATURDAY 18 OCTOBER
8.00am - 4.30pm
Registration Desk Opens reliant on breakfast session
Plaza Terrace Foyer
S-1 Plenary session 3: Immunotherapeutics Proudly sponsored by Bristol Myers Squibb
9.00am - 10.30am
10.30am - 11.00am
Chairs: Craig Lewis and Jeff Bowden
9.00am Overview - Primer on immunotherapies
9.15am Lung Cancer - Immunotherapy update
10.00am Lung Cancer Vaccines
10.15am Radiotherapy and Immunotherapy
Rina Hui
David Carbone
Paul Mitchell
Catherine Bettington
Morning Tea Poster Display & Exhibition
Plaza Auditorium
Plaza Terrace Room
S-2 New targets
Chairs - Rina Hui and Dishan Gunawardana
11.00am ALTG - Flagship results - NITRO
11.15am - Antibody drug conjugates
11.30am New immunotherapies
12.00pm After TKIs
Andrew Davidson
Craig Underhill
Ken O’Byrne
Ben Solomon
Plaza Auditorium
Narayan Karanth
Zarnie Lwin
Isabella Wallington
Barbara Page
Sabe Sabesan
Plaza P6 - P7
S-3 Lung Cancer Across the Country
Chairs: Rob Stirling and Anne Fraser
11.00am CALD - Epidemiology of lung cancer
11:15am CALD innovations
11.30am Aboriginal and Torres Straits Islander engagement in the lung
cancer space
11.00am - 12.15pm 11.45am Identifying the needs of Aboriginal and Torres Strait Islander
peoples affected by lung cancer
12.00pm Teleoncology - Way of life
S-4 Abstract orals
Chairs: David Leong and Michael MacManus
11.00am 18915 Investigating the cell-of-origin of lung cancer using mouse models
11.15am 18953 Identifying strategies to overcome acquired resistance to
EGFR TKIs and chemotherapy in NSCLC
11.30am Discussant
11.45am 19010_2 Optimisation of 3D spheroid tumour models of mesothelioma
11.55am 19031 Alterations of MET gene copy number and protein
expression in primary NSCLC and nodal metastases
12.05pm Discussant
Kate Sutherland
Csilla Hasovits
David Leong
Tian Mun (Kelly) Chee
Wendy Cooper
Plaza P8
Tom John
12.15pm - 1.45pm
Networking lunch (exhibition and poster viewing)
Plaza Terrace Room
12.30pm - 1.30pm
AstraZeneca sponsored lunch symposium: NSCLC in a molecular
diagnostic era; clinical and practical implications
Plaza P9 - P11
S-5 Looking forward
Chairs - Emily Stone and Bill Musk
1.45pm Blood tests for lung cancer
2.15pm Breath tests for lung cancer
2.35pm What is new in EBUS for the management of lung cancer?
2.55pm Surgical management of CT screening detected nodules
1.45pm - 3.30pm
Paul De Souza
Annette Dent
Kazuhiro Yasufuku
Kazuhiro Yasufuku
Plaza Auditorium
S-6 Stressing out from screening and early detection
Chairs: Tony Aouad and Natalie Doyle
1.45pm Lung cancer nurses and distress
2.05pm Lung cancer care coordinator stress - meeting timelines
2.25pm CT screening, consumer perspective
2.45pm CT screening from the primary care perspective
3.05pm - Low Dose CT screening debate - pros and cons
3.15pm Discussion
Isabella Zhao
Mary Duffy
Ian Stubbin
Danielle Matzar,
Peter Robinson (SA)
vs Paul Mitchell
All
Plaza P6 - P7
S-7 Closing Plenary Session: Access to new treatments – Right time yet?
3.30pm - 4.30 pm
4.30pm - 5.00pm
Chairs: Shane White and Martin Phillips
3.30pm Drug access - health care provider perspective
3.50pm Drug access, consumer perspective
4.10pm Discussion
4.20pm Closing ceremony
Afternoon Tea and End of Program
Michael Boyer
Richard Vines
All
Kwun Fong
Plaza P8
Plaza Terrace Foyer